Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Uropathogenic Escherichia coli | 4 | 2018 | 10 | 2.36 | Why? |
| Escherichia coli Infections | 4 | 2018 | 348 | 1.31 | Why? |
| Phenols | 2 | 2018 | 226 | 1.22 | Why? |
| Copper | 2 | 2018 | 288 | 1.10 | Why? |
| Urinary Tract Infections | 3 | 2018 | 534 | 1.01 | Why? |
| Thiazoles | 2 | 2018 | 496 | 0.99 | Why? |
| Siderophores | 2 | 2018 | 12 | 0.91 | Why? |
| Iron | 3 | 2018 | 619 | 0.71 | Why? |
| Bacteriuria | 1 | 2017 | 31 | 0.71 | Why? |
| Escherichia coli | 2 | 2018 | 1547 | 0.49 | Why? |
| Escherichia coli Proteins | 3 | 2018 | 168 | 0.49 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.48 | Why? |
| Immunization, Passive | 7 | 2021 | 10067 | 0.22 | Why? |
| Virulence | 2 | 2018 | 2172 | 0.21 | Why? |
| Genomic Islands | 1 | 2018 | 26 | 0.19 | Why? |
| Klebsiella | 1 | 2018 | 35 | 0.19 | Why? |
| Antiporters | 1 | 2018 | 11 | 0.19 | Why? |
| Yersinia pestis | 1 | 2018 | 58 | 0.18 | Why? |
| Antibiosis | 1 | 2017 | 26 | 0.18 | Why? |
| Biosynthetic Pathways | 1 | 2017 | 97 | 0.17 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.17 | Why? |
| Urinary Incontinence | 1 | 2017 | 148 | 0.16 | Why? |
| Molecular Conformation | 1 | 2017 | 374 | 0.16 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.15 | Why? |
| Liposomes | 1 | 2018 | 334 | 0.15 | Why? |
| Mannosides | 1 | 2012 | 16 | 0.13 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.12 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.12 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2012 | 170 | 0.11 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.11 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Catheter-Related Infections | 1 | 2012 | 381 | 0.09 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Models, Molecular | 1 | 2017 | 7616 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Investigational New Drug Application | 1 | 2020 | 75 | 0.05 | Why? |
| Green Fluorescent Proteins | 1 | 2020 | 450 | 0.05 | Why? |
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2017 | 1 | 0.05 | Why? |
| Biological Transport, Active | 1 | 2018 | 46 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Humans | 12 | 2021 | 930598 | 0.05 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2020 | 354 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2021 | 368 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2020 | 37182 | 0.04 | Why? |
| Models, Immunological | 1 | 2021 | 727 | 0.04 | Why? |
| Animals | 3 | 2020 | 78931 | 0.03 | Why? |
| Adhesins, Escherichia coli | 1 | 2012 | 9 | 0.03 | Why? |
| Fimbriae Proteins | 1 | 2012 | 12 | 0.03 | Why? |
| Urinary Catheters | 1 | 2012 | 35 | 0.03 | Why? |
| Bacterial Adhesion | 1 | 2012 | 69 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.03 | Why? |
| Education | 1 | 2017 | 434 | 0.03 | Why? |
| Molecular Weight | 1 | 2012 | 249 | 0.03 | Why? |
| Urinary Bladder | 1 | 2012 | 170 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Gene Deletion | 1 | 2012 | 430 | 0.03 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Cross Infection | 1 | 2012 | 8675 | 0.03 | Why? |
| Biofilms | 1 | 2012 | 304 | 0.02 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.02 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Female | 3 | 2021 | 380317 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Male | 2 | 2021 | 367725 | 0.02 | Why? |
| Adult | 1 | 2021 | 244371 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.02 | Why? |
| United States | 2 | 2020 | 46150 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2012 | 5542 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2012 | 7268 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Mice | 1 | 2012 | 21357 | 0.01 | Why? |
Henderson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_